IMPACT OF AVERAGE WEEKLY DOSE OF RADIATION DURING RADIOTHERAPY ALONE OR CHEMORADIOTHERAPY IN HEAD AND NECK CANCER

被引：8
|
作者：
Dragovic, Aleksandar F. [4 ]
Bonner, James A. [4 ]
Spencer, Sharon A. [4 ]
Nabell, Lisle M. [1 ]
Carroll, William R. [2 ]
Caudell, Jimmy J. [3 ,4 ]
机构：
[1] Univ Alabama Birmingham, Dept Internal Med, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA
[3] Univ Mississippi, Dept Radiat Oncol, Med Ctr, Mississippi, AL USA
[4] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2011年 / 33卷 / 11期
关键词：
head and neck cancer; radiotherapy; altered fractionation; chemotherapy; AWD; SQUAMOUS-CELL CARCINOMAS; LOCALLY ADVANCED HEAD; INTENSITY-MODULATED RADIOTHERAPY; ACCELERATED FRACTIONATION; LUNG-CARCINOMA; THERAPY; IRRADIATION; LARYNX; TRIAL;
D O I：
10.1002/hed.21634
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Background. Altered fractionated radiotherapy (RT) has been shown to improve locoregional control (LRC) and overall survival (OS) in squamous cell cancer of the head and neck (SCCHN). We investigated patient outcomes using a new parameter: the average weekly dose (AWD). Methods. The medical records of 601 patients who received definitive RT for SCCHN were reviewed. AWD was calculated by dividing the total dose in Gray (Gy) by overall treatment time in weeks, and assessed for predictive value. Results. Various standard RT fractionation schedules were used. An AWD >10.0 Gy was associated with improved LRC at 2 years for patients treated with RT alone (80.9% vs 60.9%; p = .006), but not for those treated with concurrent chemoradiation (75.3% vs 77.3%; p = .77). Nonsignificant increases in late dysphagia were seen with AWD >10.0 Gy. Conclusion. An AWD of >10 Gy was found to be beneficial for RT alone regimens but not chemoradiotherapy regimens. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 1551-1556, 2011
引用
收藏
页码：1551 / 1556
页数：6
相关论文
共 50 条
  • [21] WEEKLY VOLUME AND DOSIMETRIC CHANGES DURING CHEMORADIOTHERAPY WITH INTENSITY-MODULATED RADIATION THERAPY FOR HEAD AND NECK CANCER: A PROSPECTIVE OBSERVATIONAL STUDY
    Bhide, Shreerang A.
    Davies, Mark
    Burke, Kevin
    McNair, Helen A.
    Hansen, Vibeke
    Barbachano, Y.
    El-Hariry, I. A.
    Newbold, Kate
    Harrington, Kevin J.
    Nutting, Christopher M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (05): : 1360 - 1368
  • [22] Radiotherapy alone and chemoradiotherapy in rectal cancer treatment
    Schipman, B.
    Bonnet, E.
    Aherfi, L.
    Sedrati, A.
    Bosset, J. -F.
    ONCOLOGIE, 2010, 12 (01) : 37 - 40
  • [23] Eustachian Tube Functions in Concurrent Chemoradiotherapy for Head and Neck Cancer Patients
    Ohkoshi, Akira
    Ikeda, Ryoukichi
    Suzuki, Jun
    Yamamoto, Takaya
    Ishii, Ryo
    Higashi, Kenjiro
    Wakamori, Shun
    Nakayama, Yuki
    Nakanome, Ayako
    Ogawa, Takenori
    Katori, Yukio
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 3) : 6307 - 6312
  • [24] Dysphagia in Head and Neck Cancer Patients Treated with Chemoradiotherapy
    Platteaux, Nele
    Dirix, Piet
    Dejaeger, Eddy
    Nuyts, Sandra
    DYSPHAGIA, 2010, 25 (02) : 139 - 152
  • [25] Individualization of dose and fractionation of radiotherapy for head and neck cancers
    Blanchard, P.
    Biau, J.
    Castelli, J.
    Tao, Y.
    Graff, P.
    Nguyen, F.
    CANCER RADIOTHERAPIE, 2019, 23 (6-7): : 784 - 788
  • [26] Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients
    Otty, Zulfiquer
    Skinner, Monika Buhrer
    Dass, Joshua
    Collins, Michael
    Mooi, Jennifer
    Thuraisingam, Kandeepan
    Sabesan, Sabe
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (03) : 287 - 292
  • [27] Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal
    Huang, Shao Hui
    O'Sullivan, Brian
    Su, Jie
    Ringash, Jolie
    Bratman, Scott, V
    Kim, John
    Hosni, Ali
    Bayley, Andrew
    Cho, John
    Giuliani, Meredith
    Hope, Andrew
    Spreafico, Anna
    Hansen, Aaron R.
    Siu, Lillian L.
    Gilbert, Ralph
    Irish, Jonathan C.
    Goldstein, David
    de Almeida, John
    Tong, Li
    Xu, Wei
    Waldron, John
    CANCER, 2020, 126 (15) : 3426 - 3437
  • [28] Comparison of the Effect of Weekly Cisplatin Versus Three Weekly Cisplatin in Concurrent Chemoradiotherapy of Head and Neck Cancer: A Pilot Study
    Chaturvedi, Anushree
    Sehrawat, Amit
    Mopidevi, Trivikrama Rao
    Parthasarthy, K. M.
    Gupta, Deni
    Singh, Anuj
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, : 356 - 370
  • [29] Dose density of weekly cisplatin delivered concurrent with radiotherapy in head and neck cancer patients
    Laidley, H.
    Noble, D.
    Barnett, G.
    Benson, R.
    Jefferies, S.
    Gemill, J.
    Burnet, N.
    CLINICAL ONCOLOGY, 2017, 29 : S6 - S7
  • [30] Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy
    Faravel, Kerstin
    Jarlier, Marta
    Senesse, Pierre
    Huteau, Marie-Eve
    Janiszewski, Chloe
    Stoebner, Anne
    Boisselier, Pierre
    INTEGRATIVE CANCER THERAPIES, 2023, 22
12345